LCTX
Price
$0.94
Change
-$0.02 (-2.08%)
Updated
Jun 27 closing price
Capitalization
213.56M
38 days until earnings call
PYXS
Price
$1.10
Change
-$0.08 (-6.78%)
Updated
Jun 27 closing price
Capitalization
68.14M
50 days until earnings call
Interact to see
Advertisement

LCTX vs PYXS

Header iconLCTX vs PYXS Comparison
Open Charts LCTX vs PYXSBanner chart's image
Lineage Cell Therapeutics
Price$0.94
Change-$0.02 (-2.08%)
Volume$23.66M
Capitalization213.56M
Pyxis Oncology
Price$1.10
Change-$0.08 (-6.78%)
Volume$6.62M
Capitalization68.14M
LCTX vs PYXS Comparison Chart in %
Loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. PYXS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Buy and PYXS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LCTX: $0.94 vs. PYXS: $1.10)
Brand notoriety: LCTX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 1016% vs. PYXS: 1171%
Market capitalization -- LCTX: $213.56M vs. PYXS: $68.14M
LCTX [@Biotechnology] is valued at $213.56M. PYXS’s [@Biotechnology] market capitalization is $68.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, LCTX is a better buy in the long-term than PYXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 2 TA indicator(s) are bullish while PYXS’s TA Score has 2 bullish TA indicator(s).

  • LCTX’s TA Score: 2 bullish, 4 bearish.
  • PYXS’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than PYXS.

Price Growth

LCTX (@Biotechnology) experienced а -1.56% price change this week, while PYXS (@Biotechnology) price change was -5.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

LCTX is expected to report earnings on Aug 07, 2025.

PYXS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($214M) has a higher market cap than PYXS($68.1M). LCTX YTD gains are higher at: 86.109 vs. PYXS (-29.487). LCTX has higher annual earnings (EBITDA): -20.72M vs. PYXS (-83.39M). PYXS has more cash in the bank: 105M vs. LCTX (47.9M). LCTX has less debt than PYXS: LCTX (2.24M) vs PYXS (19.8M). LCTX has higher revenues than PYXS: LCTX (9.56M) vs PYXS (0).
LCTXPYXSLCTX / PYXS
Capitalization214M68.1M314%
EBITDA-20.72M-83.39M25%
Gain YTD86.109-29.487-292%
P/E RatioN/AN/A-
Revenue9.56M0-
Total Cash47.9M105M46%
Total Debt2.24M19.8M11%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
65
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LCTXPYXS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCRNF1.18N/A
N/A
Micro-Mechanics Ltd.
OTPBF50.00N/A
N/A
OTP Bank Ltd.
EXXAF8.43N/A
N/A
Exxaro Resources Ltd.
OJOC335.00N/A
N/A
Ojai Oil Co.
SITKF0.40N/A
-0.60%
Sitka Gold Corporation

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with ABCL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-3.02%
ABCL - LCTX
35%
Loosely correlated
-3.48%
ARCT - LCTX
35%
Loosely correlated
-7.49%
ATOS - LCTX
34%
Loosely correlated
+1.64%
PYXS - LCTX
34%
Loosely correlated
-6.78%
ATAI - LCTX
34%
Loosely correlated
-2.22%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-6.78%
KURA - PYXS
66%
Loosely correlated
-1.05%
ABOS - PYXS
45%
Loosely correlated
-7.44%
BEAM - PYXS
44%
Loosely correlated
-1.98%
RXRX - PYXS
43%
Loosely correlated
-6.85%
CRSP - PYXS
43%
Loosely correlated
N/A
More